Gi-Baek Ham
Technik-/Wissenschafts-/F&E-Leiter bei MEDPACTO, INC.
Ursprung des Netzwerks ersten Grades von Gi-Baek Ham
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gi-Baek Ham
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Georgia Institute of Technology | College/University | Doctorate Degree | |
| University of Iowa | College/University | Doctorate Degree | |
| Yonsei University | College/University | Undergraduate Degree | |
| Seoul National University | College/University | Corporate Officer/Principal | |
| Kyoto University | College/University | Doctorate Degree | |
| University of Tsukuba | College/University | Doctorate Degree | |
| THERAGEN ETEX CO.,LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CHA University | College/University | Corporate Officer/Principal | |
| RUSSELL CO., LTD. | Industrial Machinery | Comptroller/Controller/Auditor | |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Biotechnology | Founder |
Statistik
International
| Südkorea | 6 |
| Vereinigte Staaten | 4 |
| Japan | 3 |
Sektoral
| Consumer Services | 8 |
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 5 |
| Doctorate Degree | 4 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| Comptroller/Controller/Auditor | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Seong-Jin Kim | 5 |
| Young-Shik Kim | 3 |
| Byung-Ho Lee | 3 |
| Jeong-Im Heo | 2 |
| Seon-Jeong Kim | 2 |
- Börse
- Insiders
- Gi-Baek Ham
- Unternehmensverbindungen
